|
| 36137760 | The RSNA QIBA Profile for Amyloid PET as an Imaging Biomarker for Cerebral Amyloid Quantification. | J Nucl Med | 2023 |
| 37223334 | Hypertensive disorders of pregnancy and subsequent risk of Alzheimer's disease and other dementias. | Alzheimers Dement (Amst) | 2023 |
| 34738240 | Evaluating the Impact of Cochlear Implantation on Cognitive Function in Older Adults. | Laryngoscope | 2022 |
| 35649653 | <sup>18</sup>F-FDG PET Imaging in Neurodegenerative Dementing Disorders: Insights into Subtype Classification, Emerging Disease Categories, and Mixed Dementia with Copathologies. | J Nucl Med | 2022 |
| 35414037 | Overall and sex-specific risk factors for subjective cognitive decline: findings from the 2015-2018 Behavioral Risk Factor Surveillance System Survey. | Biol Sex Differ | 2022 |
| 34873816 | How good are medical and death records for identifying dementia? | Alzheimers Dement | 2022 |
| 32819168 | Left Ear Hearing Predicts Functional Activity in the Brains of Patients with Alzheimer's Disease Dementia. | Ann Otol Rhinol Laryngol | 2021 |
| 33712532 | Toward a Universal Readout for <sup>18</sup>F-Labeled Amyloid Tracers: The CAPTAINs Study. | J Nucl Med | 2021 |
| 32810019 | Changes in the Auditory Association Cortex in Dementing Illnesses. | Otol Neurotol | 2020 |
| 30569082 | Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer's Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers? | J Prev Alzheimers Dis | 2019 |
| 30867271 | Relative risk for Alzheimer disease based on complete family history. | Neurology | 2019 |
| 30339202 | Population Health Solutions for Assessing Cognitive Impairment in Geriatric Patients. | Arch Clin Neuropsychol | 2018 |
| 30396329 | Population Health Solutions for Assessing Cognitive Impairment in Geriatric Patients. | Clin Neuropsychol | 2018 |
| 30480142 | Population Health Solutions for Assessing Cognitive Impairment in Geriatric Patients. | Innov Aging | 2018 |
| 28077020 | Relationship between <sup>18</sup>F-Flutemetamol uptake and RBANS performance in non-demented community-dwelling older adults. | Clin Neuropsychol | 2017 |
| 28445082 | The impact of β-amyloid positron emission tomography on the diagnostic and treatment decisions of dementia experts. | Neurodegener Dis Manag | 2017 |
| 28966919 | Short-Term Practice Effects and Amyloid Deposition: Providing Information Above and Beyond Baseline Cognition. | J Prev Alzheimers Dis | 2017 |
| 25428689 | Factors associated with cognitive evaluations in the United States. | Neurology | 2015 |
| 27239516 | Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerations. | Alzheimers Dement (Amst) | 2015 |
| 26194311 | The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015. | Alzheimers Dement | 2015 |
| 25908614 | Short-Term Practice Effects and Brain Hypometabolism: Preliminary Data from an FDG PET Study. | Arch Clin Neuropsychol | 2015 |
| 25641253 | Perceptions of tissue storage in a dementia population among spouses and offspring. | J Genet Couns | 2015 |
| 25822737 | Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease. | JAMA Neurol | 2015 |
| 25408221 | Overexpression of mutant amyloid-β protein precursor and presenilin 1 modulates enteric nervous system. | J Alzheimers Dis | 2015 |
| 25457431 | The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data. | Alzheimers Dement | 2015 |
| 24492892 | Coverage with evidence development: what to consider. | JAMA Neurol | 2014 |
| 24985689 | Justifying reimbursement for Alzheimer's diagnostics and treatments: Seeking alignment on evidence. | Alzheimers Dement | 2014 |
| 24614265 | Practice effects and amyloid deposition: preliminary data on a method for enriching samples in clinical trials. | Alzheimer Dis Assoc Disord | 2014 |
| 24662628 | Relationship of hearing loss and dementia: a prospective, population-based study. | Otol Neurotol | 2014 |
| 23359661 | Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association. | J Nucl Med | 2013 |
| 24116205 | Strong evidence for a genetic contribution to late-onset Alzheimer's disease mortality: a population-based study. | PLoS One | 2013 |
| 23817438 | Amyloid deposition and cognition in older adults: the effects of premorbid intellect. | Arch Clin Neuropsychol | 2013 |
| 23809369 | Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. Amyloid Imaging Task Force of the Alzheimerâ¿¿s Association and Society for Nuclear Medicine and Molecular Imaging. | Alzheimers Dement | 2013 |
| 23753186 | Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. | J Nucl Med | 2013 |
| 23411640 | A peek behind the curtain: amyloid imaging, referrals, and specialist memory evaluations. | Alzheimer Dis Assoc Disord | 2013 |
| 23360977 | Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association. | Alzheimers Dement | 2013 |
| 22343285 | Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. | Proc Natl Acad Sci U S A | 2012 |
| 19660834 | Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. | Neurobiol Aging | 2011 |
| 21795659 | Neurology Academic Advisory Committee: a strategy for faculty retention and advancement. | Neurology | 2011 |
| 21784356 | Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease. | Alzheimers Dement | 2011 |
| 21425187 | Incidence of dementia and cognitive impairment, not dementia in the United States. | Ann Neurol | 2011 |
| 21059987 | Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors. | Arch Neurol | 2011 |
| 21276856 | Characterizing Alzheimer's disease using a hypometabolic convergence index. | Neuroimage | 2011 |
| 20202480 | Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative. | Neuroimage | 2010 |
| 21149812 | Validation of consensus panel diagnosis in dementia. | Arch Neurol | 2010 |
| 20451870 | The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. | Alzheimers Dement | 2010 |
| 20592257 | Comparing predictors of conversion and decline in mild cognitive impairment. | Neurology | 2010 |
| 20678521 | Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment. | J Neurosci Methods | 2010 |
| 19474567 | The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. | Alzheimer Dis Assoc Disord | 2009 |
| 19822868 | Relationships between biomarkers in aging and dementia. | Neurology | 2009 |